Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium
Completed
Javelin Pharmaceuticals
Phase 1
2007-03-01
The purpose of this study is to assess the pharmacokinetic parameters of intravenous
diclofenac sodium (DIC075V) 18.75 mg and 37.5 mg following single- and multiple-dose
administration, as compared to oral diclofenac potassium (CataflamĀ® 50 mg), the approved
reference product.
Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy
Completed
University of Sao Paulo
N/A
2008-03-01
The purpose of this study was to evaluate the analgesic effect of oral potassium diclofenac
in patients with proliferative diabetic retinopathy submitted to retinal photocoagulation.
Two groups of patients were followed and the effect of the treatment (diclofenac plus laser)
was compared to placebo (placebo plus laser). Pain associated with treatment was recorded
using a Visual Analog Scale 15 minutes after the procedure.
Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections
Terminated
Novartis Pharmaceuticals
Phase 4
2010-03-01
The purpose of this study is to assess if a single dose of Diclofenac potassium (0.5 mg/kg)
is more or as effective as a single dose of Acetaminophen (10 mg/kg) in the reduction of
fever during 2 hours, in the treatment of febrile children with acute upper respiratory
infections.
This is a comparative double blind, double dummy, randomized study on the effectiveness of
Diclofenac potassium versus Acetaminophen in febrile children with acute upper respiratory
tract infections. The patient will be randomized to either group: Group A (Diclofenac
potassium (0.5 mg/kg) or Group B (Acetaminophen (10 mg/kg)). A Health Care Professional
trained will measure the temperature during 2 hours. During the study period, parents or
legal representatives will be invited to fill a survey about the habits and knowledge
regarding fever management at home.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.